Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Obsessive Compulsive Treatment Efficacy Trial (OCTET) comparing the clinical and cost effectiveness of self-managed therapies: study protocol for a randomised controlled trial

Authors: Judith Gellatly, Peter Bower, Dean McMillan, Christopher Roberts, Sarah Byford, Penny Bee, Simon Gilbody, Catherine Arundel, Gillian Hardy, Michael Barkham, Shirley Reynolds, Lina Gega, Patricia Mottram, Nicola Lidbetter, Rebecca Pedley, Emily Peckham, Janice Connell, Jo Molle, Neil O’Leary, Karina Lovell

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

UK National Institute of Health and Clinical Excellence guidelines for obsessive compulsive disorder (OCD) specify recommendations for the treatment and management of OCD using a stepped care approach. Steps three to six of this model recommend treatment options for people with OCD that range from low-intensity guided self-help (GSH) to more intensive psychological and pharmacological interventions. Cognitive behavioural therapy (CBT), including exposure and response prevention, is the recommended psychological treatment. However, whilst there is some preliminary evidence that self-managed therapy packages for OCD can be effective, a more robust evidence base of their clinical and cost effectiveness and acceptability is required.

Methods/Design

Our proposed study will test two different self-help treatments for OCD: 1) computerised CBT (cCBT) using OCFighter, an internet-delivered OCD treatment package; and 2) GSH using a book. Both treatments will be accompanied by email or telephone support from a mental health professional. We will evaluate the effectiveness, cost and patient and health professional acceptability of the treatments.

Discussion

This study will provide more robust evidence of efficacy, cost effectiveness and acceptability of self-help treatments for OCD. If cCBT and/or GSH prove effective, it will provide additional, more accessible treatment options for people with OCD.

Trial registration

Current Controlled Trials: ISRCTN73535163. Date of registration: 5 April 2011
Literature
1.
Marks IM: Fears, Phobias and Rituals: Panic Anxiety, and their Disorders. 1987, Oxford: Oxford University Press
2.
Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, Jenkins R, Lewis G, Meltzer H, Singleton N: Obsessive-compulsive disorder: prevalence, comorbidity, impact and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006, 163: 1978-1985.CrossRefPubMed
3.
Bland RC, Newman SC, Orn H: Period prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand. 1988, 77 (Suppl 338): 33-42.CrossRef
4.
National Institute for Health and Clinical Excellence: National Clinical Practice Guideline Number 31: Obsessive Compulsive Disorder: Core Interventions in the Treatment of Obsessive Compulsive Disorder and Body Dysmorphic Disorder. 2006, London: National Institute for Health and Care Excellence
5.
Bower P, Gilbody S: Stepped care in psychological therapies: access effectiveness and efficiency. Narrative literature review. Br J Psychiatry. 2005, 186: 11-17.CrossRefPubMed
6.
Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P: Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess. 2006, 10: 1-168.CrossRef
7.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown obsessive compulsive scale: 1. Development, use and reliability. Arch Gen Psychiatry. 1989, 46: 1006-1011.CrossRefPubMed
8.
Ware JE, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483.CrossRefPubMed
9.
Evans C, Mellor-Clark J, Margison F, Barkham M, Audin K, Connell J, McGrath G: CORE: Clinical Outcomes in Routine Evaluation. J Ment Health. 2000, 9: 247-255.CrossRef
10.
Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999, 282: 1737-1744.CrossRefPubMed
11.
Spitzer RL, Kroenke K, Williams JB, Lowe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166: 1092-1097.CrossRefPubMed
12.
Mundt JC, Marks IM, Greist JH, Shear K: The work and social adjustment scale: a simple accurate measure of impairment in functioning. Br J Psychiatry. 2002, 180: 461-464.CrossRefPubMed
13.
Brooks R, Rabin R, de Charro F: The Measurement and Valuation of Health Status using EQ-5D: A European Perspective. 2003, Dordrecht, The Netherlands: Kluwer Academic PublishersCrossRef
14.
15.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD: Assessment of Client/patient satisfaction: development of a general scale. Eval Program Plann. 1979, 2: 197-207.CrossRefPubMed
16.
Griffin DW, Bartholomew K: The metaphysics of measurement: the case of adult attachment. Advances in Personal Relationships: Attachment Processes in Adult Relationships, Volume 5. Edited by: Bartholomew K, Perlman DP. 1994, London: Jessica Kingsley
17.
Hooley JM, Teasdale JD: Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism. J Abnorm Psychol. 1989, 98: 229-235.CrossRefPubMed
18.
Shields CG, Franks P, Harp JJ, McDaniel SH, Campbell TL: Development of the Family Emotional Involvement and Criticism Scale (FEICS): a self-report scale to measure expressed emotion. J Marital Fam Ther. 1992, 18: 395-407.CrossRef
19.
First MB, Spitzer RL, Gibbon MW, Janet BW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). 2002, New York: Biometrics Research, New York State Psychiatric Institute
20.
Lovell K, Cox D, Haddock G, Jones C, Raines D, Garvey R: Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. Br Med J. 2006, 333: 883-CrossRef
21.
Anderson RA, Rees CS, Clare S: Group versus individual cognitive-behavioural treatment for OCD: a controlled trial. Behav Res Ther. 2007, 45: 123-137.CrossRefPubMed
22.
Tolin KL, Hannan DF, Maltby S, Diefenbach N, Worhunsky P, Brady RE: A RCT of self-directed versus therapist-directed CBT for OCD patients with prior medication trials. Behav Ther. 2007, 38: 179-191.CrossRefPubMed
23.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavas J, Weiller E, Herqueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59 (Suppl 20): 22-33.PubMed
24.
Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, CONSORT group: Extending the CONSORT Statement to randomized trials of non-pharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008, 148: 295-309.CrossRefPubMed
25.
Walwyn R, Roberts C: Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity. Stat Methods Med Res. 2010, 19: 291-315.CrossRefPubMed
26.
Bower P, Garralda E, Kramer T, Harrington R, Sibbald B: The treatment of child and adolescent mental health problems in primary care: a systematic review. Fam Pract. 2001, 18: 373-382.CrossRefPubMed
27.
Knapp M, Henderson J, Patel A: Costs of obsessive-compulsive disorder: a review. Obsessive-compulsive disorder. Edited by: Maj M, Sartorius N, Okasha A, Zohar J. 2002, Chichester: John Wiley & Sons Ltd, 253-275.CrossRef
28.
Barlow JH, Ellard DR, Hainsworth JM, Jones FR, Fisher A: A review of self-management interventions for panic disorders phobias and obsessive-compulsive disorders. Acta Psychiatr Scand. 2005, 111: 272-285.CrossRefPubMed
29.
Dupont RL, Rice DP, Shiraki S, Rowland CR: Economic costs of obsessive compulsive disorder. Med Interface. 1995, 8: 102-109.PubMed
30.
Leon AC, Portera L, Weissman MM: The social costs of anxiety disorders. Br J Psychiatry. 1995, 166 (Suppl 27): 19-22.
31.
Hollander E, Broatch J, Himelein C, Rowland C, Stein D, Kwon J: Psychosocial function and economic costs of obsessive-compulsive disorder. CNS Spectr: Int J Neuropsy Med. 1997, 2: 16-25.CrossRef
32.
National Institute of Mental Health: A Real Illness: Obsessive-Compulsive Disorder. 2000, Bethesda MD: National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services, NIH Publication No:00–4676
33.
Kalra H, Kamath P, Trivedi JK, Janca A: Caregiver burden in anxiety disorders. Curr Opin Psychiatry. 2008, 21: 70-73.CrossRefPubMed
34.
McCrone P, Marks IM, Greist JH, Baer L, Kobak KA, Wenzel KW, Hirsch MJ: Cost-effectiveness of computer-aided behaviour therapy for OCD. Psychother Psychosom. 2007, 76: 249-250.PubMed
35.
Marks IM, Mataix-Cols D, Kenwright M, Cameron R, Hirsch S, Gega L: Pragmatic evaluation of computer-aided self-help for anxiety and depression. Br J Psychiatry. 2003, 183: 57-65.CrossRefPubMed
36.
Gega L, Marks I, Mataix-Cols D: Computer-aided CBT self-help for anxiety and depressive disorders: experience of a London clinic and future directions. J Clin Psychol. 2004, 60: 147-157.CrossRefPubMed
37.
Barrett B, Byford S, Crawford MJ, Patton R, Drummond C, Henry JA, Touquet R: Cost-effectiveness of referral to an alcohol health worker in patients attending an accident and emergency department: a decision-making approach. Drug Alcohol Depend. 2006, 81: 47-54.CrossRefPubMed
38.
Bower P, Byford S, Sibbald B, Ward W, King M, Lloyd M, Gabbay M: Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depresion. II: cost effectiveness. Br Med J. 2000, 321: 1389-1392.CrossRef
39.
Byford S, Knapp M, Greenshields J, Ukoumunne OC, Jones V, Thompson S, Tyrer P, Schmidt U, Davidson K, Catalan J: Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a rational decision making approach. Psychol Med. 2003, 33: 977-986.CrossRefPubMed
40.
Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. 1997, Oxford: Oxford University Press, 2
41.
Curtis L: The Unit Costs of Health and Social Care 2008 Personal Social Services Research Unit. 2008, Canterbury: University of Kent
42.
Department of Health: NHS Reference Costs 2008. 2008, London: Department of Health
43.
British Medical Association & Royal Pharmaceutical Society: British National Formulary. 2008, London: British Medical Association
44.
Koopmanschap MA, Rutten F: A practical guide for calculating indirect costs of disease. Pharmacoecon. 1996, 10: 460-466.CrossRef
45.
White IR, Thompson SG: Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005, 24: 993-1007.CrossRefPubMed
46.
Efron B, Tibshirani RJ: An Introduction to the Bootstrap. 1993, New York: Chapman & HallCrossRef
47.
Thompson SG, Barber JA: How should cost data in pragmatic randomised trials be analysed?. Br Med J. 2000, 320: 1197-1200.CrossRef
48.
Johannesson M, Weinstein MC: On the decision rules of cost-effectiveness analysis. J Health Econ. 1993, 12: 459-467.CrossRefPubMed
49.
Fenwick E, Sculpher M, Claxton K: Representing Uncertainty: the Role of Cost-Effectiveness Acceptability Curves. 2000, York: Centre for Health Economics
50.
Claxton K: The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999, 18: 341-364.CrossRefPubMed
51.
Ritchie J, Spencer L, O'Connor W: Carrying out qualitative analysis. Qualitative Research Practice. Edited by: Ritchie J, Lewis J. 2003, London: Sage Publications
Metadata
Title
Obsessive Compulsive Treatment Efficacy Trial (OCTET) comparing the clinical and cost effectiveness of self-managed therapies: study protocol for a randomised controlled trial
Authors
Judith Gellatly
Peter Bower
Dean McMillan
Christopher Roberts
Sarah Byford
Penny Bee
Simon Gilbody
Catherine Arundel
Gillian Hardy
Michael Barkham
Shirley Reynolds
Lina Gega
Patricia Mottram
Nicola Lidbetter
Rebecca Pedley
Emily Peckham
Janice Connell
Jo Molle
Neil O’Leary
Karina Lovell
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-278

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue

Research

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials

Study protocol

PAHA study: Psychological Active and Healthy Aging: psychological wellbeing, proactive attitude and happiness effects of whole-body vibration versus Multicomponent Training in aged women: study protocol for a randomized controlled trial

Study protocol

The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial

Study protocol

Thoracic Epidural analgesia versus Rectus Sheath Catheters for open midline incisions in major abdominal surgery within an enhanced recovery programme (TERSC): study protocol for a randomised controlled trial

Study protocol

A Randomized trial of an Asthma Internet Self-management Intervention (RAISIN): study protocol for a randomized controlled trial

Study protocol

Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial